SCHEMBL5220913

SCHEMBL5220913

Cn1cc(C(O)c2ccncc2)cc1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.47
KMT2A Q03164 3/20 0.40
NT5E P21589 1/20 0.40
MAPK1 P28482 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
USP2 O75604 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HRH3 Q9Y5N1 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CCNC P24863 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5218603 0.83 HTT (0.39) HTTKMT2AMAPK1SMN1; SMN2MAPT
SCHEMBL5216771 0.80 HTT (0.52) HTTKMT2ANT5EMAPK1SMN1; SMN2
SCHEMBL5216688 0.73 HTT (0.36) HTTKMT2AMAPK1SMN1; SMN2MAPT
SCHEMBL10944422 0.71 CYP2C9 (0.57) HTTKMT2AMAPK1SMN1; SMN2MAPT
SCHEMBL2907043 0.71 CYP19A1 (0.68) KMT2AMEN1CYP19A1CYP3A4
SCHEMBL5215390 0.71 ABCB11 (0.39) HTTKMT2ANT5EMAPK1SMN1; SMN2
SCHEMBL5220639 0.69 HDAC10 (0.49) HTTKMT2AMAPK1SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL5307392 0.68 HTT (0.45) HTTKMT2AMAPK1SMN1; SMN2MAPT
SCHEMBL6954324 0.68 GSK3B (0.54) HTTKMT2AMAPK1SMN1; SMN2MAPT
SCHEMBL1156055 0.67 LMNA (0.63) HTTKMT2ANT5EMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458386-B1 AROYL PYRROLE HETEROERYL AND METHANOLS USEFUL FOR TREATING A CENTRAL NERVOUS SYSTEM DISORDER ORTHO MCNEIL PHARM INC (US) 2007-04-18 EP disclosed
US-6897319-B2 Useful aroyl pyrrole heteroaryl methanones and methanols ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2005-05-24 US disclosed
EP-1458386-A1 AROYL PYRROLE HETEROERYL AND METHANOLS USEFUL FOR TREATING A CENTRAL NERVOUS SYSTEM DISORDER Ortho-McNeil Pharmaceutical, Inc. (US) 2004-09-22 EP disclosed
US-20040058980-A1 Useful aroyl pyrrole heteroaryl methanones and methanols ORTHO-MCNEIL PHARMACEUTICALS, INC. 2004-03-25 US disclosed
US-20030181481-A1 Useful aroyl pyrrole heteroaryl methanones and methanols ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-09-25 US disclosed
WO-2003057219-A1 AROYL PYRROLE HETEROERYL AND METHANOLS USEFUL FOR TREATING A CENTRAL NERVOUS SYSTEM DISORDER ORTHO-MCNEIL PHARMACEUTICAL INC. (US) 2003-07-17 WO disclosed
WO-2003057147-A2 USEFUL AROYL PYRROLE HETEROARYL METHANONES AND METHANOLS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2003-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058980-A1 Useful aroyl pyrrole heteroaryl methanones and methanols CYP11B2, NLN, CNR2 HTT 542/4885KMT2A 2816/4885NT5E 3437/4885
US-20030181481-A1 Useful aroyl pyrrole heteroaryl methanones and methanols CYP11B2, NLN, CNR2 HTT 542/4885KMT2A 2816/4885NT5E 3437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.